טוען...
The Use and Concurrent Use of Side Effect Controlling Medications Among Women on Aromatase Inhibitors
Background: Women on aromatase inhibitors (AIs) as part of their breast cancer treatment often experience difficult to control side effects. Although there are several medications to manage the side effects of AI therapy, many of them are associated with their own risk, particularly sedation. The ob...
שמור ב:
| הוצא לאור ב: | J Womens Health (Larchmt) |
|---|---|
| Main Authors: | , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Mary Ann Liebert, Inc., publishers
2021
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7826422/ https://ncbi.nlm.nih.gov/pubmed/33103945 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/jwh.2020.8493 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|